Concepedia

Tavi Nathanson

TN

Statistics

Publications

4

Citations

1.8K

H-Index

4

Active since

2016

Affiliations

Cornell University(Current)

Icahn School of Medicine at Mount Sinai

Memorial Sloan Kettering Cancer Center

Dana-Farber Cancer Institute

Swim Across America

Tavi Nathanson is an author at Cornell University specializing in immune checkpoint inhibitors, checkpoint inhibitor therapy, and immunotherapy.

ORCID

Publications per year

2016–2018

4

Publications

4

Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer

Matthew D. Hellmann, Tavi Nathanson, Hira Rizvi et al. · Cancer Cell · 2018 · 1.2K citations · Full text

, , +17

Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis

Alexandra Snyder, Tavi Nathanson, Samuel A. Funt et al. · PLoS Medicine · 2017 · 367 citations · Full text

, , +17

Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade

Tavi Nathanson, Arun Ahuja, Alex Rubinsteyn et al. · Cancer Immunology Research · 2016 · 242 citations · Full text

, , +17

Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade

Tavi Nathanson, Arun Ahuja, Alex Rubinsteyn et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2016 · 21 citations · Full text

, , +17

1–4 of 4